Positive Airway Pressure Program
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02331992 |
|
Recruitment Status :
Completed
First Posted : January 6, 2015
Results First Posted : October 29, 2018
Last Update Posted : October 29, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Obstructive Sleep Apnea (OSA) is a common sleep disordered breathing condition effecting around 2-4% of the middle aged population and is characterized by periodic collapse of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) is the primary treatment for patients with OSA. Despite the effectiveness of CPAP in abolishing upper airway obstruction, acceptance of and adherence with therapy has been sub-optimal.
Over the past decade, considerable research has focused on determining the factors responsible for poor CPAP adherence. Two key areas have been identified: patient-reported symptoms, including mask discomfort, pressure intolerance and nasal symptoms and the importance of patient education and support. In addition we know that the patient experience during the crucial first days and weeks of their journey predicts longer term adherence.
This study investigates the ability of an automated program that assists patients towards continuous positive airway pressure (CPAP) therapy adherence.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sleep Apnea, Obstructive | Behavioral: Adherence program | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 34 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Positive Airway Pressure Program |
| Study Start Date : | February 2015 |
| Actual Primary Completion Date : | July 2015 |
| Actual Study Completion Date : | September 2015 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Positive airway pressure adherence program
Participants will be enrolled in the automated adherence program and will receive supportive messages while they use CPAP as prescribed by their healthcare provider. These messages are designed to aid the participant towards therapy adherence.
|
Behavioral: Adherence program
Participants will receive supportive messages while enrolled in the program. |
- Participant Providing Feedback [ Time Frame: 1 month ]Participants will be provided questionnaires so as to provide program feedback.
- Healthcare Provider Feedback [ Time Frame: 1 month ]Healthcare providers will be provided questionaires so as to provide program feedback.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ≥ 18years of age
- Diagnosed with OSA (AHI >5 events/hour) and eligible for CPAP (fixed or auto) treatment under local requirements
- Naïve to CPAP therapy, i.e. have not been prescribed CPAP in the past 5 years
- Own a mobile phone, and has reliable mobile network coverage at their home.
- Either: the participant will use a modem; OR the participant has access to a home internet connection (either their own, or a neighbours or friend etc) and is willing to perform a home upload.
Exclusion Criteria:
- Contraindicated for CPAP therapy
- Medically unstable condition/diagnosis that is not yet under control
- Co-existing sleep disorder (however clinically diagnosed insomnia can be included in the study)
- Periodic Limb Movement Arousal Index (PLMA) greater than 15/hr during the diagnostic study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02331992
| United States, Alabama | |
| Alabama Sleep Clinic | |
| Huntsville, Alabama, United States, 35801 | |
| United States, Illinois | |
| IV Care & Respiratory | |
| Belleville, Illinois, United States, 62223 | |
| United States, South Carolina | |
| SleepMed of South Carolina | |
| Columbia, South Carolina, United States, 29201 | |
| Study Chair: | Hamish Collie, MHlthSc | Fisher & Paykel Healthcare |
| Responsible Party: | Fisher and Paykel Healthcare |
| ClinicalTrials.gov Identifier: | NCT02331992 |
| Other Study ID Numbers: |
CIA-146 |
| First Posted: | January 6, 2015 Key Record Dates |
| Results First Posted: | October 29, 2018 |
| Last Update Posted: | October 29, 2018 |
| Last Verified: | February 2018 |
|
Continuous Positive Airway Pressure |
|
Sleep Apnea, Obstructive Sleep Apnea Syndromes Apnea Respiration Disorders Respiratory Tract Diseases |
Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases |

